1. Home
  2. NEO vs HNI Comparison

NEO vs HNI Comparison

Compare NEO & HNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • HNI
  • Stock Information
  • Founded
  • NEO 2001
  • HNI 1944
  • Country
  • NEO United States
  • HNI United States
  • Employees
  • NEO N/A
  • HNI N/A
  • Industry
  • NEO Precision Instruments
  • HNI Office Equipment/Supplies/Services
  • Sector
  • NEO Health Care
  • HNI Consumer Discretionary
  • Exchange
  • NEO Nasdaq
  • HNI Nasdaq
  • Market Cap
  • NEO 1.9B
  • HNI 2.3B
  • IPO Year
  • NEO 1999
  • HNI N/A
  • Fundamental
  • Price
  • NEO $14.11
  • HNI $48.34
  • Analyst Decision
  • NEO Strong Buy
  • HNI Strong Buy
  • Analyst Count
  • NEO 10
  • HNI 1
  • Target Price
  • NEO $20.44
  • HNI $63.00
  • AVG Volume (30 Days)
  • NEO 1.2M
  • HNI 276.5K
  • Earning Date
  • NEO 02-18-2025
  • HNI 02-20-2025
  • Dividend Yield
  • NEO N/A
  • HNI 2.75%
  • EPS Growth
  • NEO N/A
  • HNI 159.58
  • EPS
  • NEO N/A
  • HNI 2.56
  • Revenue
  • NEO $644,118,000.00
  • HNI $2,563,700,000.00
  • Revenue This Year
  • NEO $13.00
  • HNI $5.42
  • Revenue Next Year
  • NEO $10.10
  • HNI $2.73
  • P/E Ratio
  • NEO N/A
  • HNI $18.83
  • Revenue Growth
  • NEO 12.06
  • HNI 10.36
  • 52 Week Low
  • NEO $12.13
  • HNI $40.50
  • 52 Week High
  • NEO $19.11
  • HNI $58.42
  • Technical
  • Relative Strength Index (RSI)
  • NEO 40.08
  • HNI 39.90
  • Support Level
  • NEO $13.76
  • HNI $47.38
  • Resistance Level
  • NEO $15.26
  • HNI $50.95
  • Average True Range (ATR)
  • NEO 0.68
  • HNI 0.79
  • MACD
  • NEO -0.02
  • HNI -0.10
  • Stochastic Oscillator
  • NEO 7.85
  • HNI 21.48

About NEO NeoGenomics Inc.

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.

About HNI HNI Corporation

HNI Corp is a provider of office furniture and hearth products. The company generates the bulk of its revenue from its workplace furnishing, which consists of panel-based and freestanding furniture systems, seating, storage, tables, and architectural products. These products are sold through a national system of dealers, wholesalers, and office product distributors but also directly to end-user customers and federal, state, and local governments. Residential building products include a full array of gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, and accessories. The company has operations in the United States, Canada, Mainland China, Hong Kong, India, Mexico, and Taiwan.

Share on Social Networks: